Evidence map›Paper›PMID 35108393›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

High Plasma Oxytocin Levels in Men With Hypersexual Disorder.

John Flanagan, Andreas Chatzittofis, Adrian Desai E Boström, Jonas Hallberg, Katarina Görts Öberg, Stefan Arver, Jussi Jokinen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Editorial: Neurodevelopment: parental influences,Frontiers in neuroscience · 2026
    Article
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

John FlanaganDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Andreas ChatzittofisMedical School, University of Cyprus, Nicosia, Cyprus.ORCID 0000-0002-6635-9564
Adrian Desai E BoströmDepartment of Clinical Sciences/Psychiatry, Umeå University, Umeå,Sweden.
Jonas HallbergDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Katarina Görts ÖbergDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Stefan ArverDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Jussi JokinenDepartment of Clinical Sciences/Psychiatry, Umeå University, Umeå,Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SEUniversity of Cyprus · CY

Funding

Stockholm County CouncilSwedish Research Council 2020-01183Umeå University and Västerbotten County Council
6 · The paper itself

Abstract

contextHypersexual disorder (HD) involves excessive, persistent sexual behaviors related to various mood states and the diagnosis compulsive sexual behavior disorder is included as an impulse control disorder in the 11th revision of the International Classification of Diseases. Although the neurobiology behind the disorder is not clear, some studies suggest dysregulated hypothalamic-pituitary-adrenal axis. Oxytocin acts as counterregulatory neuroendocrine hormone to cortisol and is also involved in sexual behavior.

objectiveWe hypothesized that oxytocin may play a role in the pathophysiology of HD with compensatory actions to cortisol.

designLongitudinal.

settingANOVA clinic (Karolinska University Hospital). PATIENTS OR OTHER

participants64 males with HD and 38 age-matched healthy volunteers.

main outcome measuresPlasma oxytocin levels, measured with radioimmunoassay; Hypersexual Disorder Screening Inventory; and Hypersexual Disorder: Current Assessment Scale for assessing hypersexual symptoms.

interventionsA patient subgroup (n = 30) completed the manual-based group-administered cognitive-behavioral therapy (CBT) program for HD, and posttreatment oxytocin levels were measured.

resultsHypersexual men (n = 64) exhibited significantly higher oxytocin plasma levels (mean ± SD: 31.0 ± 9.9 pM) compared with healthy volunteers (16.9 ± 3.9 pM; P < 0.001). There were significant positive correlations between oxytocin levels and the rating scales measuring hypersexual behavior. Patients who completed CBT treatment (n = 30) had a significant reduction of oxytocin plasma levels from pretreatment (30.5 ± 10.1 pM) to posttreatment (20.2 ± 8.0 pM; P < 0.001).

conclusionsThe results suggest that the hyperactive oxytocinergic system in hypersexual men may be a compensatory mechanism to attenuate hyperactive stress.

Indexed as

Compulsive BehaviorHypothalamo-Hypophyseal SystemOxytocinSexual BehaviorFemaleHumansHydrocortisoneMalePituitary-Adrenal SystemHydrocortisoneOxytocincognitive behavioral therapycompulsive sexual behavior disorderhypersexual disorderoxytocin

Identifiers

PMID35108393
PMCPMC9016473
OpenAlexW3020096238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.